Systems methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
AssigneeRespiratory Diagnostics, Inc.
InventorsDavid S Utley, John W Gaiser, Rachel Croft
Life of this patent
Estimating the term…
Abstract
Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.
Claims4
A method of treating fecal incontinence comprising
- selecting at least one vanilloid compound,
- providing a source of the at least one vanilloid compound,
- selecting a targeted tissue region at or near an anal sphincter,
- deploying a catheter carrying on its distal end a tissue piercing element adjacent the targeted tissue region,
- coupling the catheter to the source of the at least one vanilloid compound,
- manipulating the tissue piercing element to enter subsurface tissue in the targeted tissue region,
- injecting through the tissue piercing element the at least one vanilloid compound into the subsurface tissue.
Dependencies are inferred from the claim text.